PEAK6 Investments’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$186K Buy
5,010
+3,259
+186% +$122K ﹤0.01% 2789
2024
Q2
$83.4K Buy
+1,751
New +$76.7K ﹤0.01% 3070
2023
Q4
Sell
-594
Closed -$23.9K 4817
2023
Q3
$23.9K Sell
594
-10,436
-95% -$489K ﹤0.01% 3735
2023
Q2
$580K Buy
+11,030
New +$672K ﹤0.01% 2093
2023
Q1
Sell
-434
Closed -$28.3K 4945
2022
Q4
$21.1K Buy
+434
New +$27.2K ﹤0.01% 4002
2022
Q3
Sell
-11,030
Closed -$580K 6055
2022
Q2
$580K Buy
11,030
+9,209
+506% +$593K ﹤0.01% 3658
2022
Q1
$146K Sell
1,821
-13,972
-88% -$1.04M ﹤0.01% 4082
2021
Q4
$1.44M Sell
15,793
-4,124
-21% -$442K ﹤0.01% 2212
2021
Q3
$2.56M Buy
+19,917
New +$2.79M 0.01% 1715
2020
Q1
Sell
-4,271
Closed -$144K 4520
2019
Q4
$150K Buy
+4,271
New +$141K ﹤0.01% 2693
2019
Q1
Sell
-3,069
Closed -$109K 4582
2018
Q4
$98K Buy
+3,069
New +$120K ﹤0.01% 3405

Other funds holding STAA

PEAK6 Investments's STAA Position: Q3 2024 in Review

PEAK6 Investments increased its STAAR Surgical (STAA) stake by 186% in Q3 2024, buying an estimated $122K and bringing the position to 5,010 shares worth $186K. The position accounts for ﹤0.01% of the portfolio, ranked #2789.

PEAK6 Investments first reported a position in STAA in Q4 2018 and has held it in 11 quarters since. The position peaked at $2.56M in Q3 2021. 236 funds tracked by Wall St. Rank hold STAA as of Q3 2024.

  • PEAK6 Investments held 5,010 shares of STAAR Surgical worth $186K as of Q3 2024.
  • PEAK6 Investments bought 3,259 STAAR Surgical shares in Q3 2024, an estimated $122K.
  • STAAR Surgical made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2789 holding.
  • PEAK6 Investments first reported a position in STAAR Surgical in Q4 2018 and has held it in 11 quarters since.
  • PEAK6 Investments's STAAR Surgical position peaked at $2.56M in Q3 2021.
  • 236 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.